Ypsomed Holding AG (XSWX:YPSN) Common Stock: CHF193.1 Mil (As of Mar. 2026)


XSWX:YPSN Ypsomed Holding AG XSWX:YPSN
92 GF Score
Price CHF359.40
GF Value CHF397.11
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Ypsomed Holding AG Common Stock?

Ypsomed Holding AG XSWX:YPSN -0.33% 92 Common Stock is CHF193.1 Mil as of Mar. 2026. GuruFocus rates XSWX:YPSN with a GF Score™ of 92/100 and a GF Value™ of CHF397.11 (Fairly Valued). The stock has 4 warning signs investors should review.

Ypsomed Holding AG's quarterly common stock stayed the same from Mar. 2025 (CHF193.1 Mil) to Sep. 2025 (CHF193.1 Mil) and stayed the same from Sep. 2025 (CHF193.1 Mil) to Mar. 2026 (CHF193.1 Mil).

Ypsomed Holding AG's annual common stock stayed the same from Mar. 2024 (CHF193.1 Mil) to Mar. 2025 (CHF193.1 Mil) and stayed the same from Mar. 2025 (CHF193.1 Mil) to Mar. 2026 (CHF193.1 Mil).

Ypsomed Holding AG Common Stock Historical Data

* Premium members only.

The historical data trend for Ypsomed Holding AG's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ypsomed Holding AG Common Stock Chart

Ypsomed Holding AG Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 178.99 193.14 193.14 193.14 193.14

Ypsomed Holding AG Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 193.14 193.14 193.14 193.14 193.14
XSWX:YPSN
92GF Score
Ypsomed Holding AG XSWX:YPSN
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ypsomed Holding AG Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of CHF193.1 Mil mean?
Ypsomed Holding AG (XSWX:YPSN) has a Common Stock of CHF193.1 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Ypsomed Holding AG and its competitors.
Is Ypsomed Holding AG's Common Stock too high?
Ypsomed Holding AG's current Common Stock is CHF193.1 Mil. Overall, Ypsomed Holding AG has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's Common Stock compare to ISRG and BDX?
Ypsomed Holding AG's Common Stock of CHF193.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Ypsomed Holding AG and its competitors. Ypsomed Holding AG's current Common Stock is CHF193.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Fairly Valued. The stock's GF Value™ is CHF397.11, compared to a current price of CHF359.40 — trading 9.5% below its estimated fair value. The current Common Stock is CHF193.1 Mil. Ypsomed Holding AG's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current Common Stock is CHF193.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF359.40 is trading 9.5% below its estimated GF Value™ of CHF397.11. GuruFocus considers Ypsomed Holding AG to be Fairly Valued.

Key valuation signals for XSWX:YPSN:

  • Common Stock: CHF193.1 Mil
  • GF Value™: CHF397.11 vs. price of CHF359.40 (9.5% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ypsomed Holding AG Business Description

Other Exchanges YPSNz:UK0QLQ:UKOWX:Germany
Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
92GF Score

Get the complete analysis for XSWX:YPSN

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF359.40
Price
CHF397.11
GF Value